Shishuo Sun
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 9
- CAR-T cell therapy research 8
-
- Angiogenesis and VEGF in Cancer 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Yizhou Yao (4 shared papers)Qing Zhang (11 shared papers)Xiaoge Gao (10 shared papers)Junnian Zheng (10 shared papers)Xiong Su (3 shared papers)Nada A. Abumrad (2 shared papers)Yuqing Zhou (1 shared paper)Xinyu Shao (1 shared paper)
- Journals
- Cancer Letters (2 papers)EBioMedicine (2 papers)Biochemical and Biophysical Research Communications (1 paper)Pharmacological Research (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shishuo Sun
18 papers receiving 500 citations
Peers
Comparison fields: 5 of 71
- Oncology 152
- Immunology 118
- Biological Psychiatry 11
- Cancer Research 52
- Hepatology 23
Countries citing papers authored by Shishuo Sun
This map shows the geographic impact of Shishuo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shishuo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shishuo Sun more than expected).
Fields of papers citing papers by Shishuo Sun
This network shows the impact of papers produced by Shishuo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shishuo Sun. The network helps show where Shishuo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Shishuo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 106 | |
| 2 | 2016 | 57 | |
| 3 | 2019 | 49 | |
| 4 | Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy. | 2019 | 41 |
| 5 | 2021 | 39 | |
| 6 | Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells. | 2019 | 35 |
| 7 | 2022 | 32 | |
| 8 | 2017 | 26 | |
| 9 | 2022 | 21 | |
| 10 | 2024 | 20 | |
| 11 | 2022 | 20 | |
| 12 | 2021 | 18 | |
| 13 | 2023 | 17 | |
| 14 | 2023 | 13 | |
| 15 | 2024 | 7 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2015 | 0 |
About Shishuo Sun
Shishuo Sun is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 506 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (2 papers), Immune Cell Function and Interaction (2 papers), Immune cells in cancer (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (152 citations), Immunology (118 citations), Biological Psychiatry (11 citations), Cancer Research (52 citations) and Hepatology (23 citations). Shishuo Sun has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yizhou Yao, Qing Zhang, Xiaoge Gao, Junnian Zheng, Xiong Su, Nada A. Abumrad, Yuqing Zhou, Xinyu Shao, Tong Hu and Huiyu Wang. Their work appears in journals such as Cancer Letters, EBioMedicine, Biochemical and Biophysical Research Communications, Pharmacological Research and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.